AIRS
AirSculpt Technologies, Inc. Healthcare Medical Care Facilities
7/12
Innovation Score
Patent Activity
0/3
No patents found in USPTO database (last 2026-05-11 02:16).
Cash Runway
3/3
Operating cash flow positive — self-funding.
Cash on hand: $16.7M
Cash on hand: $16.7M
Revenue Trajectory
1/3
Revenue: $151.8M
Revenue growth data unavailable.
Revenue growth data unavailable.
Management Quality
3/3
Insider ownership: 86.1%
SBC/Revenue: 0.0%
No reverse splits detected
SBC/Revenue: 0.0%
No reverse splits detected
Key Metrics
Market Cap
$272.3M
Revenue
$151.8M
Revenue Growth (YoY)
N/A
Cash on Hand
$16.7M
Cash Runway
Cash Flow Positive
Shares Outstanding
70.5M
Insider Ownership
86.1%
SBC / Revenue
0.0%
Sector / Industry
Healthcare / Medical Care Facilities
7-Step Risk Assessment
How AIRS maps to our micro cap methodology:
- Innovation Signal No patents found. Innovation may be trade-secret-based or too early for filings.
- Cash Runway Check Cash flow positive. No dilution risk from capital raises.
- Revenue Trajectory Revenue data unavailable.
- Management Alignment Insiders hold 86.1% of shares. SBC is 0.0% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $272.3M company.
Financial Detail
Free Cash Flow
N/A
FCF Yield
N/A
Return on Equity
-12.6%
Debt / Equity
64.5%
Gross Margin
66.2%
Profit Margin
-7.4%
Operating Margin
-4.6%
Price / Book
2.67
Current Ratio
0.75
Dividend Yield
None
Share Count Change (YoY)
N/A
Share Count Change (3yr)
N/A
Free Cash Flow Trend
Insufficient Data
Consecutive Years FCF Positive
0
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: 2026-05-11